Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing klebsiella pneumoniae isolate

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 577-578

  Maherault, Anne Claire ^a   Nordmann, Patrice ^b   Therby, Audrey ^a   Pangon, Béatrice ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ACUTE PANCREATITIS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSILOMETER TEST; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEPTIC SHOCK;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84856726725     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir887     Document Type: Letter

References (8)

1. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gramnegative bacterial pathogens. Int J Med Microbiol 2010; 300:371-9.
2. Carrër A, Poirel L, Yilmaz M, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010; 54:1369-73.
3. Nordmann P, Carrer A. Carbapenemases in Enterobacteriaceae. Arch Pediatr 2010; 4: S154-62.
4. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating carbapenem? Clin Microbiol Infect 2011; 8:1135-41.
5. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 2011; 55:2420-3.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute, 2011. M02-A10 and M07-A8, M100-S20.
7. Poirel L, Ros A, Carrër A, et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J Antimicrob Chemother 2011; 66:1181-2.
8. Cuzon G, Naas T, Lesenne A, Benhamou M, Nordmann P. Plasmid-mediated carbapenemhydrolysing OXA-48 beta-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents 2010; 36:91-3.